1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell LymphomaThe First Affiliated Hospital of Nanchang UniversityRecruitingPhase 22023-08-15NCT05933967